Stock Report

All about this stock under one free report Last Updated: 02-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All
  • Home
  • Stocks
  • ImmunoCellular Therapeutics Ltd. Warrants (IMUC-WS)

ImmunoCellular Therapeutics Ltd. Warrants (IMUC-WS)

Stock Card factsheet share-fund-plan-icon

$0.46

up-down-arrow $0.02 (4.55%)

As on 17-Dec-2021EDT

Market cap

info icon

--

Revenue (TTM)

info icon

--

P/E Ratio

info icon

--

P/B Ratio

info icon

--

Div. Yield

info icon

--

ImmunoCellular Therapeutics Ltd. Warrants (IMUC-WS) Share Price

Compare

High: Low: Return:

Max: Min:

Max: Min:

Price P/E Ratio P/B Ratio
loading...
loading...
NYSE
loading...
loading...
loading...
loading...
NYSE
loading...
loading...

Stock Range

Today’s Range

Low: 0.46 High: 0.46

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    --

  • ROEROE information

    --

  • ROCEROCE information

    --

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    --

  • Debt to EquityDebt to Equity information

    --

  • Book ValueBook Value information

    --

  • EPSEPS information

    --

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    --

Years Aggregate

CFO

--

EBITDA

--

Net Profit

--

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
ImmunoCellular Therapeutics Ltd. Warrants (IMUC-WS)
12.2 -20.7 -8.0 53.3 171.4 -26.8 -10.1
BSE Sensex*
-9.1 -1.5 2.9 -3.6 5.9 6.0 10.5
As on 17-Dec-2021  |  *As on 01-Sep-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...
Quarterly Annual

*All values are in ( Cr)

loading...
Annual

*All values are in ( Cr)

loading...
Annual

*All values are in ( Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About ImmunoCellular Therapeutics Ltd. Warrants (IMUC-WS)

--

  • Chairman

    --

  • Managing Director

    --

  • Headquarters

    --

  • Website

    --

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners

FAQs for ImmunoCellular Therapeutics Ltd. Warrants (IMUC-WS)

The share price of ImmunoCellular Therapeutics Ltd Warrants (IMUC-WS) is $0.46 (NYSE) as of 17-Dec-2021 EDT. ImmunoCellular Therapeutics Ltd Warrants (IMUC-WS) has given a return of 171.44% in the last 3 years.

The 52-week high and low of ImmunoCellular Therapeutics Ltd Warrants (IMUC-WS) are Rs -- and Rs -- as of 02-Sep-2026.

ImmunoCellular Therapeutics Ltd Warrants (IMUC-WS) has a market capitalisation of -- as on 17-Dec-2021. As per SEBI classification, it is a company.

Before investing in ImmunoCellular Therapeutics Ltd Warrants (IMUC-WS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...